Published in Vaccine Weekly, October 8th, 2003
According to recent research from Germany, "Malignant melanoma is a tumor of increasing incidence. Patients with early diagnosed and surgically excised primary tumors have a high probability to be completely cured. In contrast, the prognosis of patients with distant organ metastases is still extremely poor despite a variety of therapeutical efforts that have been evaluated in numerous clinical trials."
"Cytotoxic treatment using single agents as well as polychemotherapy revealed only temporary clinical responses but no improvement of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly